Luther King Capital Management (LKCM)
EXAS

Luther King Capital Management (LKCM)’s Exact Sciences EXAS Stock Holding History

Luther King Capital Management (LKCM)’s Portfolio EXAS Stock Details EXAS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-32,749
Closed -$3.33M – 612
2025
Q4 		$3.33M Hold
32,749
– – 0.01% 298
2025
Q3 		$1.79M Hold
32,749
– – 0.01% 355
2025
Q2 		$1.74M Hold
32,749
– – 0.01% 346
2025
Q1 		$1.42M Hold
32,749
– – 0.01% 365
2024
Q4 		$1.84M Hold
32,749
– – 0.01% 334
2024
Q3 		$2.23M Buy
32,749
+54
+0.2% +$3.05K 0.01% 306
2024
Q2 		$1.38M Buy
32,695
+50
+0.2% +$2.75K 0.01% 357
2024
Q1 		$2.25M Sell
32,645
-135
-0.4% -$8.54K 0.01% 307
2023
Q4 		$2.43M Buy
32,780
+10
+0% +$655 0.01% 300
2023
Q3 		$2.24M Sell
32,770
-283
-0.9% -$24K 0.01% 305
2023
Q2 		$3.1M Buy
33,053
+328
+1% +$25.6K 0.02% 277
2023
Q1 		$2.22M Hold
32,725
– – 0.01% 295
2022
Q4 		$1.62M Hold
32,725
– – 0.01% 322
2022
Q3 		$1.06M Hold
32,725
– – 0.01% 371
2022
Q2 		$1.29M Hold
32,725
– – 0.01% 353
2022
Q1 		$2.29M Buy
+32,725
New +$2.39M 0.01% 295
2021
Q1 		– Sell
-6,650
Closed -$881K – 558
2020
Q4 		$881K Hold
6,650
– – 0.01% 383
2020
Q3 		$678K Buy
6,650
+830
+14% +$71.7K ﹤0.01% 374
2020
Q2 		$506K Sell
5,820
-120
-2% -$9.59K ﹤0.01% 399
2020
Q1 		$345K Sell
5,940
-325
-5% -$26.4K ﹤0.01% 422
2019
Q4 		$579K Sell
6,265
-45
-0.7% -$3.96K ﹤0.01% 406
2019
Q3 		$570K Hold
6,310
– – ﹤0.01% 390
2019
Q2 		$745K Hold
6,310
– – 0.01% 359
2019
Q1 		$547K Sell
6,310
-950
-13% -$80.9K ﹤0.01% 392
2018
Q4 		$458K Hold
7,260
– – ﹤0.01% 408
2018
Q3 		$573K Buy
+7,260
New +$473K ﹤0.01% 413
2016
Q1 		– Sell
-866,010
Closed -$7.99M – 512
2015
Q4 		$7.99M Sell
866,010
-698,445
-45% -$6.49M 0.07% 208
2015
Q3 		$28.1M Buy
1,564,455
+125,565
+9% +$2.88M 0.27% 96
2015
Q2 		$42.8M Sell
1,438,890
-115,085
-7% -$2.89M 0.37% 72
2015
Q1 		$34.2M Sell
1,553,975
-481,250
-24% -$12.2M 0.29% 89
2014
Q4 		$55.8M Buy
2,035,225
+278,180
+16% +$6.77M 0.45% 65
2014
Q3 		$34.1M Sell
1,757,045
-42,660
-2% -$782K 0.28% 96
2014
Q2 		$30.6M Sell
1,799,705
-106,230
-6% -$1.46M 0.24% 120
2014
Q1 		$27M Sell
1,905,935
-70,460
-4% -$952K 0.22% 138
2013
Q4 		$23.2M Sell
1,976,395
-38,410
-2% -$441K 0.19% 153
2013
Q3 		$23.8M Sell
2,014,805
-12,835
-0.6% -$165K 0.2% 157
2013
Q2 		$28.2M Buy
+2,027,640
New +$22M 0.26% 125

Other funds holding EXAS

VanEck Associates
VanEck Associates New York $133B AUM 72.99% 1-Year Est. Return
Wealth Enhancement Advisory Services
Wealth Enhancement Advisory Services Plymouth, Minnesota $59.8B AUM 29.42% 1-Year Est. Return
PRS
Pinkerton Retirement Specialists Coeur D Alene, Idaho $1.16B AUM 28.78% 1-Year Est. Return
PWMAG
Pinnacle Wealth Management Advisory Group Red Bank, New Jersey $1.68B AUM 31.18% 1-Year Est. Return
IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return
HNB
Huntington National Bank Columbus, Ohio $18.1B AUM 24.69% 1-Year Est. Return
BC
Broadwater Capital Boston, Massachusetts $138M AUM 28.86% 1-Year Est. Return

Luther King Capital Management (LKCM)'s EXAS Position: Q1 2026 in Review

Luther King Capital Management (LKCM) sold out of Exact Sciences (EXAS) in Q1 2026, closing a stake of 32,749 shares — an estimated $3.33M sold.

Luther King Capital Management (LKCM) first reported a position in EXAS in Q2 2013 and held it in 37 quarters. The position peaked at $55.8M in Q4 2014. 7 funds tracked by Wall St. Rank hold EXAS as of Q1 2026.

  • Luther King Capital Management (LKCM) reported no remaining Exact Sciences position as of Q1 2026 after selling out during the quarter.
  • Luther King Capital Management (LKCM) sold 32,749 Exact Sciences shares in Q1 2026, an estimated $3.33M.
  • Luther King Capital Management (LKCM) first reported a position in Exact Sciences in Q2 2013 and held it in 37 quarters.
  • Luther King Capital Management (LKCM)'s Exact Sciences position peaked at $55.8M in Q4 2014.
  • 7 funds tracked by Wall St. Rank held Exact Sciences as of Q1 2026.

Based on Luther King Capital Management (LKCM)'s 13F filing for Q1 2026, filed 11 May 2026.